As of June 2024 Kinnate Biopharma has a market cap of $0.12 Billion. This makes Kinnate Biopharma the world's 7328th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | 11.94% |
2023 | $0.11 B | -58.55% |
2022 | $0.26 B | -65.33% |
2021 | $0.77 B | -55.07% |
2020 | $1.72 B |
On Jun 17th, 2024 the market cap of Kinnate Biopharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.48 B | 287.30% | ๐บ๐ธ USA |